DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kreisel W, Deibert P, Kupcinskas L. , et al.
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study.
Dig Liver Dis 2015;
47 (02) 144-150
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.